相关实验视频
Updated: May 25, 2025

Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
在口服固体剂量制造中混合统一性和内容统一性:一个IQ联盟行业立场论文
Manel Bautista1, Seb Caille2, Claudia Corredor3
1Process Analytical Technologies at Synthetic Molecules Technical Development, F. Hoffmann-La Roche AG, Basel, Switzerland. manel.bautista@roche.com.
本研究引入了基于风险的方法来测试混合物统一性 (BU) 和含量统一性 (CU),旨在简化制药制造工艺并减少为剂量单位统一性 (UDU) 进行不必要的采样.
科学领域:
- 制药制造业 制药制造业 制药制造业
- 质量控制 质量控制 质量控制
- 监管科学 监管科学
背景情况:
- 目前的混合物统一性 (BU) 和含量统一性 (CU) 测试实践在各制药公司之间存在差异.
- 现有测试发生在关键阶段:过程设计,过程合格和持续验证.
研究的目的:
- 审查和协调BU和CU的测试实践.
- 为BU和CU测试制定基于风险的方法.
- 提出减少或消除混合样本采集的方法.
主要方法:
- 十家IQ财团成员公司目前的BU/CU测试实践的审查.
- 基于风险的战略的开发,使用先前的知识和机制的理解.
- 创建一个决策树,将配方分类为低风险或高风险.
主要成果:
- 为BU和CU测试建立了一个结构化的风险评估框架.
- 提出了创新方法,以减少基于对剂量单位 (UDU) 统一性测试风险的混合样本采样.
- 一个决策树指导低风险和高风险配方的测试策略.
结论:
- 提出的基于风险的方法可以优化BU和CU测试策略.
- 通过影响卫生当局,可以实现简化测试期望.
- 减少混合采样可以导致更高效的制药制造.
更多相关视频
11:27A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
13:17Manufacture of Concentrated, Lipid-based Oxygen Microbubble Emulsions by High Shear Homogenization and Serial Concentration
Published on: May 26, 2014
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Bioequivalence: Overview
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Delivery: Enteral Route